V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction. [electronic resource]
Producer: 20091224Description: 960-7 p. digitalISSN:- 1523-1755
- Angiotensin II Type 1 Receptor Blockers -- pharmacology
- Angiotensin-Converting Enzyme Inhibitors -- pharmacology
- Animals
- Antidiuretic Hormone Receptor Antagonists
- Benzazepines -- blood
- Biomarkers -- blood
- Blood Pressure -- drug effects
- Body Weight -- drug effects
- Chronic Disease
- Disease Models, Animal
- Disease Progression
- Diuresis -- drug effects
- Drinking -- drug effects
- Drug Therapy, Combination
- Eating -- drug effects
- Enalapril -- pharmacology
- Hormone Antagonists -- blood
- Kidney -- drug effects
- Kidney Diseases -- drug therapy
- Losartan -- pharmacology
- Male
- Nephrectomy
- Proteinuria -- drug therapy
- Rats
- Rats, Sprague-Dawley
- Receptors, Vasopressin -- metabolism
- Renin-Angiotensin System -- drug effects
- Spiro Compounds -- blood
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.